Company news
electroCore, Inc. news in 2021
electroCore, Inc.'s news releases, calls and decks from 2021, newest first.
electroCore, Inc. Provides Update on Global Distribution Partners
December 15, 2021
electroCore, Inc. Announces The Launch of a New Online Shop in the United Kingdom
December 14, 2021
electroCore Announces New Patent for Stroke and TIA Treatment
December 12, 2021
electroCore Announces Third Quarter 2021 Financial Results
November 3, 2021
electroCore to Announce Third Quarter 2021 Financial Results on Thursday, November 4th
October 20, 2021
electroCore Announces Publication Reviewing the Prescribing of gammaCore for the Treatment of Cluster Headache in England
October 19, 2021
electroCore Announces Regulatory Approval in Canada to Treat Adolescent Migraine
October 13, 2021
electroCore Provides Business Update and Select Third Quarter 2021 Financial Guidance
October 11, 2021
electroCore Announces Open Access and Submission of Manuscript from SAVIOR-1 study of Non-Invasive Vagus Nerve Stimulation (nVNS) in Hospitalized COVID-19 Patients
September 28, 2021
electroCore Announces Peter Cuneo as Board Chairman
September 19, 2021
electroCore Announces New Patent Expanding Claims Related to Delivery of Non-Invasive Vagus Nerve Stimulation Therapy Using Mobile Devices
September 14, 2021
electroCore Announces 510(k) Clearance of gammaCore™ Non-Invasive Vagus Nerve Stimulation (nVNS) to Treat Paroxysmal Hemicrania and Hemicrania Continua
September 13, 2021
electroCore Announces New Reseller Agreement with Red One Medical Devices, LLC.
August 23, 2021
electroCore Announces Second Quarter 2021 Financial Results
August 4, 2021
electroCore Announces Publication in PharmacoEconomics Reiterating Economic Benefits of gammaCore for Cluster Headache Outlined by The National Institute for Health and Care Excellence (NICE) Medical Technologies Guidance
August 3, 2021
electroCore Announces Issuance of New Patent for Migraine Treatment using Smartphones
July 26, 2021
electroCore to Announce Second Quarter 2021 Financial Results on Thursday, August 5th
July 21, 2021
electroCore announces Dr. Peter Staats to receive Lifetime Achievement Award from the American Society of Pain and Neuroscience
July 18, 2021
electroCore Provides Business Update and Select Second Quarter 2021 Financial Guidance
July 12, 2021
electroCore Announces Pricing of $18.0 Million Public Offering of Common Stock
June 29, 2021
electroCore Announces Proposed Public Offering of Common Stock
June 28, 2021
electroCore Announces Publication of Study on the Effect of non-invasive Vagus Nerve Stimulation (nVNS) on Cognitive Performance Caused by Sleep Deprivation
June 23, 2021
electroCore, Inc. Announces Exclusive Distribution Agreement with Kromax For Taiwan and China
June 22, 2021
electroCore Completes Sale of $1.4 Million of NJ NOL Tax Benefits
June 8, 2021
electroCore Announces Publication of Study on Non-Invasive Vagus Nerve Stimulation (nVNS) to Improve Clinical Outcomes and Molecular Biomarkers in Parkinson’s Disease Patients
June 1, 2021
electroCore Announces First Quarter 2021 Financial Results
May 5, 2021
electroCore, Inc. Announces U.S. Department of Veterans Affairs Study of gammaCore Sapphire™ (Non-Invasive Vagus Nerve Stimulator) for the Treatment of Post-Traumatic Headache
May 3, 2021
electroCore to Announce First Quarter 2021 Financial Results on Thursday, May 6
April 28, 2021
electroCore, Inc. Announces Johns Hopkins University School of Medicine Study of Non-Invasive Vagus Nerve Stimulation (nVNS) for Symptomatic Exacerbation of Nausea in Patients with Gastroparesis and Related Disorders
April 25, 2021
electroCore, Inc. Announces Exclusive Distribution Agreement with East Agency For Qatar
April 19, 2021
electroCore Provides Business Update and Select First Quarter 2021 Financial Guidance
April 12, 2021
electroCore Announces Top Line Results from SAVIOR-1 study of Non-Invasive Vagus Nerve Stimulation (nVNS) in Hospitalized COVID-19 Patients
April 7, 2021
electroCore, Inc. Announces Regulatory Approval in Canada
April 4, 2021
electroCore, Inc. Announces Exclusive Distribution Agreement with Silvert Medical Nv-Sa. For Western Europe
March 22, 2021
electroCore Announces Fourth Quarter and Full Year 2020 Financial Results
March 10, 2021
electroCore to Announce Fourth Quarter and Year Ended December 31, 2020 Financial Results on Thursday, March 11
March 3, 2021
electroCore Inc. Announces Exclusive Distribution Agreement with Medistar Following Regulatory Approval in Australia
February 27, 2021
electroCore Announces Two-Year Extension of gammaCore™ Listing in the NHS Supply Chain Catalogue
February 22, 2021
electroCore Announces 510(k) Clearance of gammaCore™ Non-Invasive Vagus Nerve Stimulation (nVNS) to Treat Adolescent Migraine
February 15, 2021
electroCore Announces Completion of Enrollment in SAVIOR-1 Study of Non-Invasive Vagus Nerve Stimulation (nVNS) in COVID-19 Patients Exhibiting Respiratory Symptoms
February 10, 2021
electroCore Announces Publication of Study on Non-Invasive Vagus Nerve Stimulation (nVNS) to Reduce Ileus After Major Colorectal Surgery
February 8, 2021
electroCore Announces Full Enrollment of TR-VENUS study of Non-Invasive Vagal Nerve Stimulation (nVNS) for the Acute Treatment of Stroke
February 1, 2021
electroCore, Inc. Announces Inclusion of gammaCore Sapphire™ in new NHS England and NHS Improvement MedTech Funding Mandate Policy 2021/22
January 26, 2021
electroCore, Inc. Announces Exclusive Distribution Agreement with RSK Medical Inc. in Canada
January 25, 2021
electroCore, Inc. Announces Scottish Health Technology Group Recommendation For Use of gammaCore™ in NHS Scotland Cluster Headache Patients
January 20, 2021
electroCore, Inc. Announces the Establishment of a Unique Level II HCPCS Code for “Non-Invasive Vagus Nerve Stimulator”
January 18, 2021
Calls in 2021
Decks in 2021
- Investor Presentation (August 2021)
Investor deck · 23 slides · August 2021